Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028

Ascendis is redeeming $575M in notes.

Risk flags

• ●The majority of claims are forward-looking or contingent on future events, specifically the actual redemption in 2026.
• ●There is a lack of operational or financial context—no information on cash flow, profitability, or debt service.

Announcement summary

Ascendis Pharma A/S announced the redemption of all $575.0 million aggregate principal amount of its outstanding 2.25% Convertible Senior Notes due 2028. The redemption will occur on May 6, 2026. The company's right to redeem the notes is based on the last reported sale price per ordinary share exceeding 130% of the conversion price on at least 20 trading days during a 30 consecutive trading day period ending April 21, 2026. The notes were issued under an indenture dated March 29, 2022, with U.S. Bank Trust Company, National Association as trustee. This action is significant for investors holding the notes.

Disagree with this article?